Coya Therapeutics (COYA) Restructuring Costs (2024 - 2026)

Coya Therapeutics (COYA) has 3 years of Restructuring Costs data on file, last reported at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Restructuring Costs fell 3.3% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (up 23.66% YoY), and the FY2025 full-year result was $5.5 million, up 20.27% from the prior year.
• Restructuring Costs fell to $1.3 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $1.5 million in Q2 2025 to a low of $991941.0 in Q4 2024.
• A 3-year average of $1.3 million and a median of $1.3 million in 2026 frame the typical range for Restructuring Costs.
• Peak annual rise in Restructuring Costs reached 49.66% in 2025, while the deepest fall reached 10.83% in 2025.
• Tracing COYA's Restructuring Costs over 3 years: stood at $991941.0 in 2024, then jumped by 49.66% to $1.5 million in 2025, then slipped by 13.07% to $1.3 million in 2026.
• Business Quant data shows COYA's Restructuring Costs at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.